|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2009-3-16
|
|
pubmed:abstractText |
To assess available evidence on the use of end-points (outcome measures) in clinical trials in systemic lupus erythematosus (SLE), as a part of the development of evidence-based recommendations for points to consider in clinical trials in SLE.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1468-2060
|
|
pubmed:author |
pubmed-author:BertsiasG KGK,
pubmed-author:BoletisJJ,
pubmed-author:BombardieriSS,
pubmed-author:BoumpasD TDT,
pubmed-author:CerveraRR,
pubmed-author:DostalCC,
pubmed-author:FontJJ,
pubmed-author:GilboeI MIM,
pubmed-author:GordonCC,
pubmed-author:HoussiauFF,
pubmed-author:HuizingaTT,
pubmed-author:IoannidisJ P AJP,
pubmed-author:IsenbergDD,
pubmed-author:KallenbergC G MCG,
pubmed-author:KhamashtaMM,
pubmed-author:PietteJ CJC,
pubmed-author:SchneiderMM,
pubmed-author:SmolenJJ,
pubmed-author:SturfeltGG,
pubmed-author:TincaniAA,
pubmed-author:van VollenhovenRR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
68
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
477-83
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints.
|
|
pubmed:affiliation |
Internal Medicine, and Rheumatology, Clinical Immunology and Allergy, University of Crete School of Medicine, Heraklion, Greece.
|
|
pubmed:publicationType |
Journal Article,
Review,
Research Support, Non-U.S. Gov't,
Practice Guideline
|
